• Scientific Publications and Presentations - Urology

    Center for Reconstructive Urologic Surgery

    Journal Publications

    • Palmer DA, Buckley JC, Zinman LZ, Vanni AJ. Urethroplasty for high-risk, long segment urethral strictures with ventral buccal mucosa graft and gracilis flap. J Urol. In press. 
    • Kent M, Zinman LZ, Girshovich L, Sands J, Vanni AJ. Combined chemoradiation as primary treatment for invasive male urethral cancer. J Urol. In press. 
    • Kowalik C, Stoffel JT, Zinman L, Vanni AJ, Buckley JC. Intermediate outcomes after female urethral reconstruction: graft vs flap. Urology. 2014 May;83(5):1181-5.
    • Leddy LS, Vanni AJ, Wessells H, Voelzke BB. Outcomes of endoscopic realignment of pelvic fracture associated urethral injuries at a level 1 trauma center. JUrol. 2012 Jul;188(1):174-8. doi: 10.1016/j.juro.2012.02.2567. Epub 2012 May 15. PubMed PMID: 22591965; PubMed Central PMCID: PMC3444143.
    • Vanni AJ, Hotaling J, Hamlat C, Jurkovich GJ, Voelzke BB. Do inclusive trauma systems improve outcomes after renal trauma? J Trauma Acute Care Surg. 2012Feb;72(2):385-9. doi: 10.1097/TA.0b013e3182411c67. PubMed PMID: 22327981; PubMedCentral PMCID: PMC3281515.
    • Buckley JC, Zinman LN. Removal of endoprosthesis with urethral preservation and simultaneous urethral reconstruction. J Urol. 2012 Sep;188(3):856-60. doi:10.1016/j.juro.2012.05.018. Epub 2012 Jul 20. PubMed PMID: 22819407.
    • Vanni AJ, Zinman LN, Buckley JC. Radial urethrotomy and intralesional mitomycin C for the management of recurrent bladder neck contractures. J Urol. 2011 Jul;186(1):156-60. Epub 2011 May 14.
    • Vanni AJ, Stoffel JT. Ileovesicostomy for the neurogenic bladder patient: outcome and cost comparison of open and robotic assisted techniques. Urology. 2011 Jun;77(6):1375-80. Epub 2010 Dec 13.
    • Vanni AJ, Buckley JC, Zinman LN.Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft. J Urol. 2010 Dec;184(6):2400-4. Epub 2010 Oct 16.
    • Vanni AJ, Bennett NE. Current treatment and management of the acute phase of Peyronies's disease. Arch Esp Urol. 2009 Oct;62(8):614-22. Review. Spanish.
    • Vanni AJ, Cohen MS, Stoffel JT. Robotic-assisted ileovesicostomy: initial results. Urology. 2009 Oct;74(4):814-8. Epub 2009 Jul 16. PubMed PMID: 19615716.
    • Cohen MS, Triaca V, Billmeyer B, Hanley RS, Girshovich L, Shuster T, Oberfield RA, Zinman L.  Coordinated Chemoradiation Therapy with Genital Preservation in the Treatment of Primary Invasive Carcinoma of the Male Urethra.  The Journal of Urology. Vol. 179; February 2008.

    Book Chapters

    • Vanni AJ. Trauma to the external genitalia. Chapter 7. In: Wessells HB; eds. Urological Emergencies: A practical approach, Current Clinical Urology-2nd edition, Springer Science + Business Media, New York, 2013, pp85-102.
    • Vanni AJ, Wessells H. Injuries to the Urogenital Tract Section 7. Chapter 11. In: Souba, W.W., Fink, M.P., Jurkovich, G.J., Kaiser, L.R., Pemberton, J.H., Soper, N.J.; eds. ACS Surgery. Online edition. Hamilton, Ontario: Decker Publishing, 2011.
    • Leonard Zinman.  Combined use of fasciocutaneous, muscular and myocutaneous flaps and graft onlays in urethral reconstruction.  Textbook of Reconstructive Urologic Surgery, First Edition, Chapter 60, 2008.
    • Leonard Zinman.  Contemporary Management of Rectourethral Fistulas.  Reconstructive Urologic Surgery. Cleveland Clinic; 2008.
    • Latini, J; Stoffel, J; Zinman, L.  “The Acture Posterior Urethral Injury”.  Reconstructive Urethral Surgery.  Edited by F Schreiter and J Jordan.  Heidelberg, Germany, Springer.  Publication date 09/2005.

    Center for Sexual Medicine

    Center for Minimally Invasive Surgery

    Journal Publications

    Center for Urologic Oncology

    Journal Publications

    • Kowalik C, Gee JR, Sorcini A, Moinzadeh A, Canes D. Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP. Can J Urol. 2014 Jun;21(3):7266-70
    • Martínez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Nguyen HG, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Faba OR, Russo P, Shariat SF, Spahn M, Terrone C, Tilki D, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep. 2014 May;15(5):404.
    • Harty NJ, Kozinn SI, Canes D, Sorcini A, Moinzadeh A. Comparison of positive surgical margin rates in high risk prostate cancer: open versus minimally invasive radical prostatectomy. Int Braz J Urol. 2013 Sep-Oct;39(5):639-46; discussion 647-8.
    • Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, Levan L, Jarrard D, Wilding G. Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin. Prostate. 2013 Jun;73(9):970-8.
    • Tilki D, Nguyen HG, Dall'era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus. Eur Urol. 2013 Jul 10.
    • Corcoran AT, Russo P, Lowrance WT, Asnis-Alibozek A, Libertino JA, Pryma DA, Divgi CR, Uzzo RG. A Review of Contemporary Data on Surgically Resected Renal Masses-Benign or Malignant? Urology. 2013 Feb 26. doi:pii: S0090-4295(13)00032-0.10.1016/j.urology.2013.01.009. [Epub ahead of print] PubMed PMID: 23453080.
    • Flacke S, Harty NJ, Laskey DH, Moinzadeh A, Benn JA, Villani R, Kalra A,Libertino JA, Madras PN. Targeted endovascular temporary vessel occlusion with a reverse thermosensitive polymer for near-bloodless partial nephrectomy: comparison to standard surgical clamping techniques. Cardiovasc Intervent Radiol. 2012 Oct;35(5):1163-71. Epub 2011 Dec 9. PubMed PMID: 22160093.
    • Libertino JA. Off-clamp versus complete hilar control laparoscopic partial nephrectomy: comparison by clinical stage. BJU Int. 2012 May;109(9):1381. doi: 10.1111/j.1464-410X.2011.10604.x. Epub 2011 Oct 12. PubMed PMID: 21992612.
    • Hegarty P, Gee J, Clark P, Svatek R, Hegarty N, Kamat A. ICUD-EAU International Consultation on Bladder Cancer 2011: Bladder Cancer Diagnosis and Evaluation. Eur Urol. 2013 Jan;63(1):4-15. doi: 10.1016/j.eururo.2012.09.057. Epub 2012 Oct 4.
    • Edward Messing, Jason R. Gee, Daniel R. Saltzstein, KyungMann Kim, Anthony diSant'Agnese, Jill Kolesar, Linda Harris, Adrienne Faerber, Thomas Havighurst, Jay M. Young, Mitchell Efros, Robert H. Getzenberg, Marcia A. Wheeler, Joseph Tangrea, Howard Parnes, Margaret House, J. Erik Busby, Raymond Hohl, Howard Bailey. A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients.  Cancer Prev Res (Phila). 2012 Apr;5(4):621-30. doi: 10.1158/1940-6207.CAPR-11-0455. Epub 2012 Jan 31.
    • Canes D, Moinzadeh A, Sorcini A. Re: Saint Elie et al.: Impact of laparoscopic inguinal hernia mesh on open radical retropubic prostatectomy (Urology 2010;76:1078-1082). Urology. 2011 Apr;77(4):1012-3; author reply 1013. doi:10.1016/j.urology.2010.12.062. PubMed PMID 21477736.
    • Martínez-Salamanca JI, Huang WC, Millán I, Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernández C, Herranz F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martínez-Ballesteros C, Montorsi F, Palou J, Pontes JE, Russo P, Terrone C, Villavicencio H, Volpe A, Libertino JA; International Renal Cell Carcinoma-Venous Thrombus Consortium. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol. 2011 Jan;59(1):120-7. Epub 2010 Oct 13.
    • Gee J, Hegarty P, Rawal S. ICUD/EAU International Consultation on Bladder Cancer 2011: Diagnosis, Pathology, Markers, Ta/Low Grade Disease, Ta/High Grade Disease, T1 and CIS, Prostate Involvement by Urothelial Cell Carcinoma, Chemotherapy: Bladder Cancer Diagnosis and Evaluation.
    • Libertino JA. OFF-CLAMP VERSUS COMPLETE HILAR CONTROL LAPAROSCOPIC PARTIAL NEPHRECTOMY: COMPARISON BY CLINICAL STAGE. BJU Int. 2011 Oct 12. doi: 10.1111/j.1464-410X.2011.10604.x. [Epub ahead of print]
    • Harty NJ, Moinzadeh A, Flacke S, Pettit J, Benn JA, Libertino JA, Madras PN. Temporary targeted hemostasis to facilitate bloodless partial nephrectomy. Urology. 2011 Dec;78(6):1435-41.
    • Flacke S, Harty NJ, Laskey DH, Moinzadeh A, Benn JA, Villani R, Kalra A, Libertino JA, Madras PN. Targeted Endovascular Temporary Vessel Occlusion with a Reverse Thermosensitive Polymer for Near-Bloodless Partial Nephrectomy: Comparison to Standard Surgical Clamping Techniques. Cardiovasc Intervent Radiol. 2011 Dec 9. [Epub ahead of print]
    • Wszolek MF, Kenney PA, Libertino JANonclamping partial nephrectomy: towards improved nephron sparing. Nat Rev Urol. 2011 Aug 2;8(9):523-7. doi: 10.1038/nrurol.2011.103.
    • Smith GL, Kenney PA, Lee Y, Libertino JA. Non-clamped partial nephrectomy: techniques and surgical outcomes. BJU Int. 2011 Apr;107(7):1054-8. doi: 10.1111/j.1464-410X.2010.09798.x. Epub 2010 Oct 29.
    • Wszolek MF, Kenney PA, Lee Y, Libertino JA. Comparison of hilar clamping and non-hilar clamping partial nephrectomy for tumours involving a solitary kidney. BJU Int. 2011 Jun;107(12):1886-92. doi: 10.1111/j.1464-410X.2010.09713.x. Epub 2010 Nov 11.
    • Flacke S, Moinzadeh A, Libertino JA, Merhige J, Vogel JM, Lyall K, Khettry U, Bakal CW, Madras PN. Endovascular temporary vessel occlusion with a reverse-thermosensitive polymer for bloodless minimally invasive renal surgery. J Vasc Interv Radiol. 2010 May;21(5):711-8. Epub 2010 Mar 21.
    • Lerner SP, Grossman HB, Messing EM, Kibel AS, Stephenson A, Gee JR, O'Donnell MA, Reid RD, Kamat AM, Parnes HL, House MG. BCAN Think Tank session 3: Prevention of bladder cancer. Urol Oncol. 2010 May-Jun;28(3):338-42.
    • Moinzadeh A, Flacke S, Libertino JA, Merhige J, Vogel JM, Lyall K, Bakal CW, Madras PN. Temporary segmental renal artery occlusion using reverse phase polymer for bloodless robotic partial nephrectomy. J Urol. 2009 Oct;182(4):1582-7. Epub 2009 Aug 15.
    • Jason R. Gee, Corrie Burmeister, Thomas Havighurst, Kyung Mann Kim. Cyclin-Mediated G1 Arrest by Celecoxib Differs in Low versus High Grade Bladder Cancer. Anticancer Research, 29:3769-3776, 2009.
    • Kenney PA, Wszolek MF, Gould JJ, Libertino JA, Moinzadeh A. Face, content, and construct validity of dV-trainer, a novel virtual reality simulator for robotic surgery. Urology. 2009 Jun;73(6):1288-92. Epub 2009 Apr 10. Moinzadeh A, Flacke S, Libertino JA, Merhige J, Vogel JM, Lyall K, Bakal CW, Madras PN.
    • Cohen M, Hanley R, Kurteva T, Ruthazer R, Silverman M, Sorcini A, Hamawy K, Roth R, Tuerk I, Libertino J.  Comparing the Gleason Prostate Biopsy and Gleason Prostatectomy Grading System: The Lahey Clinic Medical Center Experience and an International Meta-Analysis. Eur Urol. 2008 Aug;54(2):371-81. Epub 2008 Mar 28.
    • Wszolek M, Wotkowicz C, Libertino JA. Surgical Management of Large Renal Tumors. Nat Clin Pract Urol. 2008 Jan;5(1):35-46. Review.
    • Wotkowicz C, Wszolek MF, Libertino JA. Resection of renal tumors invading the vena cava. Urol Clin North Am. 2008 Nov;35(4):657-71; viii. Review.

    Book Chapters

    • Libertino, John A.  Renal Cancer: Contemporary Management. Springer, New York, 2013

    Center for Endourology: Continence Center

    Journal Publications

    Ian C. Summerhayes Cell and Molecular Biology Lab

    Journal Articles

    • Kozinn SI, Harty NJ, Delong JM, Deliyiannis C, Logvinenko T, Summerhayes IC, Libertino JA, Holway AH, Rieger-Christ KM. MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines. Genes Cancer. 2013 Jan;4(1-2):61-9.
    • Flacke S, Harty NJ, Laskey DH, Moinzadeh A, Benn JA, Villani R, Kalra A,
    • Libertino JA, Madras PN. Targeted endovascular temporary vessel occlusion with a
    • reverse thermosensitive polymer for near-bloodless partial nephrectomy:
    • comparison to standard surgical clamping techniques. Cardiovasc Intervent Radiol.
    • 2012 Oct;35(5):1163-71. Epub 2011 Dec 9. PubMed PMID: 22160093.
    • Harty NJ, Laskey DH, Moinzadeh A, Flacke S, Benn JA, Villani R, Kalra A, Libertino JA, Madras PN.  Temporary targeted renal blood flow interruption using a reverse thermosensitive polymer to facilitate bloodless partial nephrectomy: a swine survival study. BJU Int. 2012.
    • Harty NJ, Moinzadeh A, Flacke S, Pettit J, Benn JA, Libertino JA, Madras PN. Temporary targeted hemostasis to facilitate bloodless partial nephrectomy. Urology. 2011 Dec;78(6):1435-41.
    • Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, Zeheb R, Libertino JA, Summerhayes IC.  A MicroRNA Expression Profile Defining the Invasive Bladder Tumor Phenotype.  Urol. Oncol. 2011 Nov;29(6):794-801.e1.Epub 2009 Nov 27.
    • Kenney PA, Wszolek MF, Rieger-Christ KM, Neto BS, Gould JJ, Harty NJ, Mosquera JM, Zeheb R, Loda M, Darling DS, Libertino JA, Summerhayes IC. Novel ZEB1 expression in bladder tumorigenesis. BJU Int. 2011 Feb;107(4):656-63. doi: 10.1111/j.1464-410X.2010.09489.x. Epub 2010 Aug 24.
    • Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Libertino JA, Whitney D, Summerhayes IC.  A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol. 2010 Jan-Feb;28(1):39-48. Epub 2008 Sep 16.
    • Gould JJ; Kenney PA, Rieger-Christ KM, Silva Neto B, Wszolek MF, Holway A; Spurrier B, Austin J; Libertino JA, Summerhayes IC.  Identification of Tumor and Invasive Suppressor Gene Modulators in Bladder Cancer by Different Classes of Histone Deacetylase Inhibitors Using Reverse Phase Protein Arrays  J Urol. 2010 Jun;183(6):2395-402. Epub 2010 Apr 18.
    • Moinzadeh A, Flacke S, Libertino JA, Merhige J, Vogel JM, Lyall K, Bakal CW, Madras PN. Temporary segmental renal artery occlusion using reverse phase polymer for bloodless robotic partial nephrectomy. J Urol. 2009 Oct;182(4):1582-7. Epub 2009 Aug 15.
    • Patrick A. Kenney, Matthew F. Wszolek, Kimberly M. Rieger-Christ, Brasil Silva Neto, Justin J. Gould, Niall J. Harty, Juan Miguel Mosquera, Ron Zeheb, Massimo Loda, Douglas S. Darling, John A. Libertino, Ian C. Summerhayes.  Novel ZEB1 Expression in Bladder Tumorigenesis.  BJU Int. (accepted Feb 18th published 2009).
    • Fernandez CA, Wszolek MF, Duchesne AR, Feng Y, Patel S, Robison L, Libertino JA, Summerhayes IC, Shuber AP.  A Novel Approach to Utilizing Matrix Metalloproteinases (MMPs) in the Management of Bladder Cancer Patients  J. Urol. 182: 2188-2194, 2009.
    • Mandeville JA, Silva Neto B, Vanni AJ, Smith GL, Rieger-Christ KM, Zeheb R, Loda M, Libertino JA and Summerhayes IC.  P-cadherin is a Modulator of Migration in Bladder Carcinoma Cells.  (submitted Clin. Cancer Res. 2008).
    • Mandeville JA, Silva Neto B, Vanni AJ, Smith GL, Rieger-Christ KM, Zeheb R, Loda M, Libertino JA, Summerhayes IC.  P-cadherin as a Prognostic Indicator and a Modulator of Migratory Behavior in Bladder Carcinoma Cells.  BJU Int. 102:1707-1714, 2008.
    • Neely LA, Rieger-Christ KM,  Silva Neto B, Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Libertino JA, Whitney D, Summerhayes IC.  A microRNA expression ratio defining the invasive phenotype in bladder tumors.  Urol. Oncol. (in press 2008).
    • Silva Neto B, Smith GL, Mandeville JA, Vanni AJ, Wotkowicz C, Rieger-Christ KM, Baumgart E, Jacobs MA, Cohen MS, Zeheb R, Loda M, Libertino JA and Summerhayes IC.  Prognostic Significance of Altered p120ctn Expression in Bladder Cancer.  Br. J. Urol. Int. 101(6):746-52, 2008.
    • Baumgart E, Cohen MS, Silva Neto B, Jacobs M, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA and Summerhayes IC.  Identification and prognostic significance of an epithelial to mesenchymal expression profile in human bladder tumors. Clin. Cancer Res. 13(6):1685-1694, 2007. 
    • Jacobs MA, Wotkowicz C, Baumgart ED, Silva Neto B, Rieger-Christ KM, Bernier T, Cohen MS, Libertino JA, Summerhayes IC.  Epidermal Growth Factor Receptor Status and the Response of Bladder Carcinoma Cells to Erlotinib.  J. Urol. 178(4): 1510-1514, 2007.
    • Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, S. Le Meé, P.J. Marie, Libertino JA and Summerhayes IC.  The Green Tea Compound, (-) - Epigallocatechin-3-gallate Down-Regulates N-Cadherin and Suppresses Migration of Bladder Carcinoma Cells.  J. Cell. Biochem. 102(2):377-388, 2007.
  • Make An Appointment

    (781) 744-8762
  • "Clampless" Surgery a Success

    John A. Libertino, MD, chair, Institute of Urology, and director, Sophia Gordon Cancer Center, recently presented the findings of nearly 20 years of retrospective clinical data demonstrating that long term kidney function is significantly improved in cancer patients when their kidney tumor is removed via a new “clampless” variation of the traditional surgical procedure known as a partial nephrectomy.